Status:
COMPLETED
Impact of C-arm CT in Patients With HCC Undergoing TACE: Optimal Imaging Guidance
Lead Sponsor:
Stanford University
Collaborating Sponsors:
Siemens Healthcare Diagnostics Inc
Conditions:
Carcinoma, Hepatocellular
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Patients will be enrolled based on presence of HCC and eligibility for TACE. They will be randomized to one of two arms for imaging navigation to the optimal catheter location for chemotherapy injecti...
Detailed Description
We hope to learn more about the utility of C-arm CT in patients undergoing TACE for HCC. Data will be evaluated with regards to: 1. Sensitivity and specificity to diagnose additional tumors and its i...
Eligibility Criteria
Inclusion
- Patients must be affected by HCC
- Patients must be 18 years old or older
- Patients must have received an abdominal CT, PET/CT scan or MRI, completed prior to the TACE procedure.
- Ability to understand and the willingness to sign a written informed consent document.
Exclusion
- Subjects under the age of 18
- Pregnant women
Key Trial Info
Start Date :
April 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2010
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT00926536
Start Date
April 1 2009
End Date
March 1 2010
Last Update
April 4 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University School of Medicine
Stanford, California, United States, 94305